Correction
Correction
https://doi.org/10.1161/01.ATV.0000157494.59480.2e
Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:472
Originally published January 27, 2005See original article:
Jump to

In the January 2005 issue of Arteriosclerosis, Thrombosis, and Vascular Biology, in the ATVB In Focus article entitled “Immunomodulation of Atherosclerosis: Implications for Vaccine Development” by Nilsson et al (Arterioscler Thromb Vasc Biol, 2005;25:18–28), the footnote disclosing the Consulting Editor for the article was not included.
Consulting Editor for this article was Alan M. Fogelman, MD, Professor of Medicine and Executive Chair, Departments of Medicine and Cardiology, UCLA School of Medicine, Los Angeles, CA.
This Issue
Arteriosclerosis, Thrombosis, and Vascular Biology
February 2005, Volume 25, Issue 2
Jump to
Article Tools
- CorrectionArteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:472, originally published January 27, 2005https://doi.org/10.1161/01.ATV.0000157494.59480.2e
Citation Manager Formats







